A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2Hanjun Zhao, Kwok‐Yung Yuen, Hin Chu et al.|Nature Communications|2020Cited by 115
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2Hanjun Zhao, Kwok‐Yung Yuen, Kelvin Kai‐Wang To et al.|Nature Communications|2021Cited by 61
Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron VariantKa-Wa Khong, Ivan Fan‐Ngai Hung, Danlei Liu et al.|Vaccines|2022Cited by 42
A broad-spectrum virus- and host-targeting antiviral peptide against SARS-CoV-2 and other respiratory virusesHanjun Zhao, Kwok‐Yung Yuen, Kelvin Kai‐Wang To et al.|Research Square|2020Cited by 4